Abstract
It is a great pleasure to participate in this, the first international conference brought together to discuss the Chemical, Biological and Clinical Aspects of Triazenes. This paper deals mainly with the chemistry of triazenes; the biological properties of these compounds will be discussed in detail in other chapters of these proceedings. However, where appropriate, the anti-tumour activity of relevant compounds will be described briefly here.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
K. Vaughan and M.F.G. Stevens. Ghem. Soc. Review. 7, 377 (1978)
T.P. Ahern and K. Vaughan. J. Chem. Soc. Chem. Comm. 701 (1973).
T.P. Ahern, H. Fong and K. Vaughan. Can. J. Chem. 55 1701 (1977).
K. Vaughan. J. Chem. Soc. Perkin Trans. II. 17 (1977).
C.J. Rutty, D.R. Newell, R.B. Vincent, G. Abel, P.M. Goddard, S.J. Harland and A.H. Calvert. Brit. J. Cancer. 48, 140 (1983).
A. Gescher, J.A. Hickman, R.J. Simmonds, M.F.G. Stevens and K. Vaughan. Tetrahedron Letters. 5041 (1978).
R.J. LaFrance, Y. Tang, K. Vaughan and D.L. Hooper. J. Chem. Soc. Chem. Comm. 721 (1983).
S.C. Cheng, L. Fernandez, J. Iley and E. Rosa. J. Chem. Res. (S). 108 (1983).
H.W. Manning, C.M. Hemens, R.J. LaFrance, Y. Tang and K. Vaughan. Can. J. Chem. 62, 749 (1984).
K. Vaughan, Y. Tang, G. Llanos, J.K. Horton, R.J. Simmonds, J.A. Hickman and M.F.G. Stevens, J. Med. Chem. 21, 357 (1984).
R.J. Simmonds and C.H. Schwalbe. Unpublished results.
N.W. Gibson, J. Hartley, R.J. LaFrance and K. Vaughan. Carcinogenesis. 7, 259 (1986).
CM. Hemens, H.W. Manning, K. Vaughan, R.J. LaFrance and Y. Tang. Can. J. Chem. 62, 741 (1984).
C.M. Hemens and K. Vaughan. J. Chem. Soc. Perkin Trans II. 11 (1986)
K. Vaughan, K.U.K. Gamage Nicholas, R.D. Singer, M. Roy and N.W. Gibson. Anti-Cancer Drug Design. 2, 279 (1987).
M. Overton, J.A. Hickman, M.D. Threadgill, K. Vaughan and A. Gescher. Biochem. Pharmacol. 34, 2055 (1985).
R.J. LaFrance, H.W. Manning and K. Vaughan. J. Org. Chem. 50. 2229 (1985).
R.D. Singer, K. Vaughan and D.L. Hooper. Can. J. Chem. 64, 1567 (1986).
L.M. Cameron, R.J. LaFrance, C.M. Hemens, K. Vaughan, R. Rajaraman, D.C Chubb and P.M. Goddard. Anti-Cancer Drug Design. 1, 27 (1985).
J. Iley, E. Rosa and L. Fernandes. J. Chem. Res. (S). 264 (1987).
K. Vaughan, H.W. Manning, M.P. Merrin and D.L. Hooper. Can. J. Chem. 66, 2487 (1988).
M.P. Merrin, R.J. LaFrance and K. Vaughan. Unpublished results.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Vaughan, K. (1990). Triazenes: Synthesis and Chemical Properties. In: Giraldi, T., Connors, T.A., Cartei, G. (eds) Triazenes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3832-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3832-5_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6710-9
Online ISBN: 978-1-4615-3832-5
eBook Packages: Springer Book Archive